Inventor · disambiguated record
Dharmpal S. Dodd
Also filed as: DODD DHARMPAL S
43 granted patents·6 pending applications·225 citations·filing 2002–2025
97Inventor score
Top patents by PatentIndex Score
49 records- 0196USRE49880E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 26, 2024·2 cites·20 claims
- 0296US10544143B24-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·10 cites·27 claims
- 0396US7723336B2Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 25, 2010·50 cites·16 claims
- 0495US11053244B14-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 6, 2021·6 cites·7 claims
- 0595US10912766B2[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 9, 2021·6 cites·17 claims
- 0693US10730877B24-Azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 4, 2020·6 cites·13 claims
- 0791USRE49893E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 2, 2024·1 cites·17 claims
- 0891US11180474B2Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 23, 2021·6 cites·14 claims
- 0991US10071079B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 11, 2018·6 cites·20 claims
- 1091US7601844B2Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 13, 2009·19 cites·8 claims
- 1191US7517900B2Pyrazole derivatives as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 14, 2009·28 cites·32 claims
- 1289US10478424B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 19, 2019·5 cites·17 claims
- 1388US8987311B2Triazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 24, 2015·14 cites·16 claims
- 1487US11299501B2Diazaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 12, 2022·3 cites·8 claims
- 1586US10660877B2Pyridyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 26, 2020·6 cites·18 claims
- 1686US2023255941A1[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1785US11447466B2Substituted indole compounds useful as inhibitors of TLR7/8/9BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 20, 2022·3 cites·7 claims
- 1885US11427580B26-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 30, 2022·3 cites·9 claims
- 1985US11420973B2Amide substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 23, 2022·3 cites·9 claims
- 2085US11306092B2Amino indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 19, 2022·3 cites·10 claims
- 2184US7375237B2Pyrrolizine compounds useful as anti-inflammatory agentsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 20, 2008·4 cites·5 claims
- 2283US7459460B2Trisubstituted heteroaromatic compounds as calcium sensing receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 2, 2008·16 cites·16 claims
- 2382US10953032B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 23, 2021·2 cites·20 claims
- 2482US9556179B2Substituted imidazoles as casein kinase 1 D/E inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 31, 2017·9 cites·15 claims
- 2581USRE49931E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 23, 2024·0 cites·17 claims
- 2680US7985861B2Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jul 26, 2011·3 cites·13 claims
- 2779US9492460B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·4 cites·15 claims
- 2878US10053454B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 21, 2018·3 cites·5 claims
- 2977US11660311B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 30, 2023·2 cites·17 claims
- 3075US11672780B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 13, 2023·0 cites·13 claims
- 3173US11820768B24-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 21, 2023·0 cites·10 claims
- 3272US2025320183A1Modulators of BCL6 as Ligand Directed DegradersCELGENE CORP·Filed 2025·Application pending·0 cites
- 3369US8389527B2Substituted imidazopyridazines useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Mar 5, 2013·1 cites·12 claims
- 3468US12404239B2Modulators of BCL6 as ligand directed degradersCELGENE CORP·Filed 2023·Granted Sep 2, 2025·0 cites·10 claims
- 3568US11739098B2Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 29, 2023·0 cites·12 claims
- 3667US11912703B26-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Feb 27, 2024·0 cites·8 claims
- 3766US9475817B2Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 25, 2016·1 cites·12 claims
- 3861US11339185B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 24, 2022·0 cites·11 claims
- 3958US10519187B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 31, 2019·0 cites·70 claims
- 4057US12384760B2Substituted carbazole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 12, 2025·0 cites·13 claims
- 4152US2021253593A1Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 4250US2011245226A1Piperidinyl derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 4349US12030878B2Substituted indole ether compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 9, 2024·0 cites·7 claims
- 4448US10196387B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·0 cites·5 claims
- 4546US11878975B2Substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 23, 2024·0 cites·14 claims
- 4645US2007078136A1Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 4744US10744150B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 18, 2020·0 cites·54 claims
- 4843US7091202B24-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 15, 2006·0 cites·10 claims
- 4940US2002183335A12, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulatorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dharmpal S. Dodd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →